Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 3284 entries
View as:

Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00227305 Org: User:
Start: 08/31/04 End: 12/31/07 Due: 12/31/08

Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00680745 Org: User:
Start: 04/30/08 End: 05/31/10 Due: 05/31/11

A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension

Phase: N/A Priority: Normal
NCT ID: NCT00894322 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00288379 Org: User:
Start: 10/31/04 End: 05/31/06 Due: 05/31/07

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00237900 Org: User:
Start: 07/31/03 End: 02/29/04 Due: 02/28/05

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

Phase: N/A Priority: Normal
NCT ID: NCT00634309 Org: User:
Start: 06/30/99 End: 05/31/03 Due: 05/31/04

A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Status in Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT05918042 Org: User:
Start: 06/21/23 End: 07/31/25 Due: 07/31/26

Selumetinib Paediatric NF1 Japan Study

Phase: N/A Priority: Normal
NCT ID: NCT04495127 Org: User:
Start: 08/31/20 End: 03/24/23 Due: 03/24/24

Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01103609 Org: User:
Start: 04/30/10 End: 08/31/10 Due: 08/31/11

Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)

Phase: N/A Priority: Normal
NCT ID: NCT00163384 Org: User:
Start: 01/31/04 End: 05/31/05 Due: 05/31/06

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00421122 Org: User:
Start: 09/30/06 End: 11/30/07 Due: 11/30/08

Lynparza Breast Cancer Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT03590938 Org: User:
Start: 08/14/18 End: 03/24/22 Due: 03/24/23

Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

Phase: N/A Priority: Normal
NCT ID: NCT00659594 Org: User:
Start: 11/30/04 End: 09/30/05 Due: 09/30/06

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01365533 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00916604 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00956280 Org: User:
Start: 09/30/09 End: 04/30/10 Due: 04/30/11

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

Phase: N/A Priority: Normal
NCT ID: NCT00790153 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid

Phase: N/A Priority: Normal
NCT ID: NCT00692705 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00859898 Org: User:
Start: 04/30/09 End: 05/31/10 Due: 05/31/11

Esomeprazole (NEXIUM) vs. Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00251927 Org: User:
Start: 10/31/01 End: 04/30/09 Due: 04/30/10

AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02780830 Org: User:
Start: 06/30/16 End: 04/30/19 Due: 04/30/20

A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02902809 Org: User:
Start: 11/11/16 End: 01/19/18 Due: 01/19/19

Rosuvastatin Impact on Ventricular Remodelling Lipids and Cytokines

Phase: N/A Priority: Normal
NCT ID: NCT00240292 Org: User:
Start: 02/28/03 End: - Due: -

A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia

Phase: N/A Priority: Normal
NCT ID: NCT02875834 Org: User:
Start: 03/03/17 End: 02/14/18 Due: 02/14/19

Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00836160 Org: User:
Start: 08/31/09 End: 09/30/12 Due: 09/30/13